[go: up one dir, main page]

NL300011I1 - Afgedichte houder, bevattend een voor injectie ge rede zure oplossing, die in hoofdzaak bestaat uit een fysiologisch aanvaardbaar zout van een antracyclineglycoside opgelost in een fysiologisch water bevattend oplosmiddel daarvoor. - Google Patents

Afgedichte houder, bevattend een voor injectie ge rede zure oplossing, die in hoofdzaak bestaat uit een fysiologisch aanvaardbaar zout van een antracyclineglycoside opgelost in een fysiologisch water bevattend oplosmiddel daarvoor.

Info

Publication number
NL300011I1
NL300011I1 NL300011C NL300011C NL300011I1 NL 300011 I1 NL300011 I1 NL 300011I1 NL 300011 C NL300011 C NL 300011C NL 300011 C NL300011 C NL 300011C NL 300011 I1 NL300011 I1 NL 300011I1
Authority
NL
Netherlands
Prior art keywords
ready
injection
acceptable salt
consisting essentially
physiologically acceptable
Prior art date
Application number
NL300011C
Other languages
English (en)
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10583216&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL300011(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NL300011I1 publication Critical patent/NL300011I1/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
NL300011C 1985-08-02 2000-07-18 Afgedichte houder, bevattend een voor injectie ge rede zure oplossing, die in hoofdzaak bestaat uit een fysiologisch aanvaardbaar zout van een antracyclineglycoside opgelost in een fysiologisch water bevattend oplosmiddel daarvoor. NL300011I1 (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858519452A GB8519452D0 (en) 1985-08-02 1985-08-02 Injectable solutions

Publications (1)

Publication Number Publication Date
NL300011I1 true NL300011I1 (nl) 2000-10-02

Family

ID=10583216

Family Applications (2)

Application Number Title Priority Date Filing Date
NL8601698A NL191507C (nl) 1985-08-02 1986-06-27 Afgedichte houder, bevattend een voor injectie gerede zure oplossing, die in hoofdzaak bestaat uit een fysiologisch aanvaardbaar zout van een antracyclineglycoside opgelost in een fysiologisch water bevattend oplosmiddel daarvoor.
NL300011C NL300011I1 (nl) 1985-08-02 2000-07-18 Afgedichte houder, bevattend een voor injectie ge rede zure oplossing, die in hoofdzaak bestaat uit een fysiologisch aanvaardbaar zout van een antracyclineglycoside opgelost in een fysiologisch water bevattend oplosmiddel daarvoor.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL8601698A NL191507C (nl) 1985-08-02 1986-06-27 Afgedichte houder, bevattend een voor injectie gerede zure oplossing, die in hoofdzaak bestaat uit een fysiologisch aanvaardbaar zout van een antracyclineglycoside opgelost in een fysiologisch water bevattend oplosmiddel daarvoor.

Country Status (34)

Country Link
US (1) US4946831A (nl)
JP (1) JPH0655667B2 (nl)
KR (1) KR920001773B1 (nl)
CN (1) CN1064531C (nl)
AT (1) AT397463B (nl)
BE (1) BE905202A (nl)
BG (1) BG60425B2 (nl)
CA (1) CA1291037C (nl)
CH (2) CH690490C2 (nl)
CS (1) CS277561B6 (nl)
CY (1) CY1592A (nl)
DE (1) DE3621844C2 (nl)
DK (1) DK167557B1 (nl)
ES (1) ES8801580A1 (nl)
FI (1) FI86800C (nl)
FR (1) FR2585569B1 (nl)
GB (2) GB8519452D0 (nl)
GR (1) GR861556B (nl)
HK (1) HK93990A (nl)
HU (1) HU196123B (nl)
IE (1) IE59297B1 (nl)
IL (1) IL79129A (nl)
IT (1) IT1204906B (nl)
NL (2) NL191507C (nl)
NO (1) NO170913C (nl)
NZ (1) NZ216604A (nl)
PH (1) PH22332A (nl)
PT (1) PT82865B (nl)
RU (2) RU1837883C (nl)
SE (1) SE466383C (nl)
SG (1) SG80690G (nl)
UA (1) UA29383C2 (nl)
YU (1) YU44788B (nl)
ZA (1) ZA864792B (nl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124318A (en) * 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.R.L. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
FI91710C (fi) * 1986-12-05 1994-08-10 Erba Carlo Spa Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi
FI883338A7 (fi) * 1987-07-16 1989-01-17 Bristol Myers Squibb Co Doksorubisiinihydrokloridin vesiliuoksia
FI883337A7 (fi) * 1987-07-16 1989-01-17 Bristol Myers Squibb Co Doksorubisiinihydrokloridin ei-vesiliuoksia
DE3801178A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierte trockenzubereitung zytostatisch wirksamer anthracyclin-antibiotika und verfahren zu ihrer herstellung
EP0372889B1 (en) * 1988-12-05 1993-03-24 Bristol-Myers Squibb Company Doxorubicin solutions
FI895733A7 (fi) * 1988-12-05 1990-06-06 Bristol Myers Squibb Co Doksorubisiinin vesiliuoksia
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
DE19544532C2 (de) * 1995-11-29 1997-12-11 Pharma Dynamics Gmbh Verfahren zum Herstellen eines Doxorubicin-Lyophilisats
DE69609845T2 (de) * 1996-12-16 2000-12-21 Pharmachemie B.V., Haarlem Verfahren zur Herstellung von Epirubicin oder Zusatzsalzen davon, von Daunorubicin
DE69737510T2 (de) 1996-12-30 2007-12-06 Battelle Memorial Institute, Columbus Verwendung eines unverkapselten Antikrebs-Arzneimittels zur Herstellung einer Zubereitung zur Behandlung von Neoplasmen durch Inhalation
US20090253220A1 (en) * 2003-10-28 2009-10-08 Sukanta Banerjee Absorbing Biomolecules into Gel-Shell Beads
US20070004653A1 (en) * 2005-05-11 2007-01-04 Roberto Arosio Stable lyophilized anthracycline glycosides
WO2013063286A1 (en) * 2011-10-25 2013-05-02 Nektar Therapeutics Treatment of patients suffering from cancer
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB1457632A (en) * 1974-03-22 1976-12-08 Farmaceutici Italia Adriamycins
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
US4039663A (en) * 1975-03-19 1977-08-02 Societa' Farmaceutici Italia S.P.A. Daunomycins, process for their uses and intermediates
FR2314726A1 (fr) * 1975-06-16 1977-01-14 Rhone Poulenc Ind Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
GB1511559A (en) * 1975-09-26 1978-05-24 Farmaceutici Italia Anthracycline glycosides
FR2397425A1 (fr) * 1977-07-11 1979-02-09 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
DE2738656A1 (de) * 1977-08-26 1979-03-08 Microbial Chem Res Found Anthracyclinglycoside, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4177264A (en) * 1977-10-17 1979-12-04 Sri International N-benzyl anthracyclines
GB2007645B (en) * 1977-10-17 1982-05-12 Stanford Res Inst Int Benzyl anthracyclines and pharmaceutical compositions containing them
FR2430425A1 (fr) * 1978-07-07 1980-02-01 Rhone Poulenc Ind Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2433027A1 (fr) * 1978-08-08 1980-03-07 Rhone Poulenc Ind Nouveau procede de preparation de derives de la doxorubicine
US4325947A (en) * 1981-05-12 1982-04-20 Farmitalia Carlo Erba S.P.A. 4-Demethoxy-4'-deoxydoxorubicin
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
JPS6092212A (ja) * 1983-10-26 1985-05-23 Kyowa Hakko Kogyo Co Ltd ドキソルビシン塩の製剤
FI91710C (fi) * 1986-12-05 1994-08-10 Erba Carlo Spa Menetelmä injektoitavan käyttövalmiin, säilytystä kestävän, steriilin antrasykliiniglykosidiliuoksen valmistamiseksi

Also Published As

Publication number Publication date
CH668911C1 (de) 2000-05-31
ES8801580A1 (es) 1988-02-16
GB2178311A (en) 1987-02-11
ZA864792B (en) 1988-02-24
DK306286A (da) 1987-02-03
KR870001828A (ko) 1987-03-28
US4946831A (en) 1990-08-07
AU5885886A (en) 1987-02-12
FR2585569B1 (fr) 1990-01-19
CY1592A (en) 1992-04-03
FR2585569A1 (fr) 1987-02-06
NL191507C (nl) 2000-02-16
HU196123B (en) 1988-10-28
JPS6248629A (ja) 1987-03-03
FI862629A0 (fi) 1986-06-19
IE861598L (en) 1987-02-02
IL79129A (en) 1992-03-29
NZ216604A (en) 1989-10-27
AT397463B (de) 1994-04-25
CH668911A5 (de) 1989-02-15
RU1837883C (ru) 1993-08-30
CN1064531C (zh) 2001-04-18
FI862629L (fi) 1987-02-03
DK167557B1 (da) 1993-11-22
NL8601698A (nl) 1987-03-02
AU598197B2 (en) 1990-06-21
SE466383B (sv) 1992-02-10
SE8602743D0 (sv) 1986-06-19
UA29383C2 (uk) 2000-11-15
NO862587D0 (no) 1986-06-26
NO862587L (no) 1987-02-03
GR861556B (en) 1986-10-17
HUT42326A (en) 1987-07-28
SE466383C (sv) 1996-02-19
FI86800C (fi) 1999-10-28
YU44788B (en) 1991-02-28
CS277561B6 (en) 1993-03-17
GB8614800D0 (en) 1986-07-23
GB8519452D0 (en) 1985-09-11
HK93990A (en) 1990-11-23
SE8602743L (sv) 1987-02-03
KR920001773B1 (ko) 1992-03-02
NO170913B (no) 1992-09-21
CA1291037C (en) 1991-10-22
DE3621844C2 (de) 1994-02-17
DK306286D0 (da) 1986-06-27
JPH0655667B2 (ja) 1994-07-27
DE3621844A1 (de) 1987-03-05
PH22332A (en) 1988-07-29
BG60425B2 (bg) 1995-03-31
IT1204906B (it) 1989-03-10
IT8620917A0 (it) 1986-06-26
CN86104283A (zh) 1987-01-28
GB2178311B (en) 1989-10-11
NO170913C (no) 2003-10-10
SG80690G (en) 1990-11-23
CH690490C2 (de) 2000-09-29
IE59297B1 (en) 1994-02-09
ES556291A0 (es) 1988-02-16
IL79129A0 (en) 1986-09-30
YU103586A (en) 1988-04-30
NL191507B (nl) 1995-04-18
ATA176886A (de) 1993-09-15
PT82865A (en) 1986-07-01
BE905202A (fr) 1987-02-02
FI86800B (fi) 1992-07-15
RU2110263C1 (ru) 1998-05-10
PT82865B (pt) 1989-01-17
CS470886A3 (en) 1992-11-18

Similar Documents

Publication Publication Date Title
NL300011I1 (nl) Afgedichte houder, bevattend een voor injectie ge rede zure oplossing, die in hoofdzaak bestaat uit een fysiologisch aanvaardbaar zout van een antracyclineglycoside opgelost in een fysiologisch water bevattend oplosmiddel daarvoor.
DE3669104D1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
NL300045I2 (nl) Fluorcytidine-derivaten, de bereiding daarvan en geneesmiddelen die deze derivaten bevatten.
DE3874453D1 (de) Wasserloesliche fuellmittel.
FI880163L (fi) Menetelmä lääkeaineena käytettävän liuoksen valmistamiseksi
NO884820D0 (no) Sementeringspreparat og vandig hydraulisk sementeringsopploesning innbefattende vannopploeselig, ikke-ionisk hydrofobt modifisert hydroksyetylcellulose.
DE69001730D1 (de) Pastenfoermige, waesserige pharmazeutische zusammensetzungen.
DE3480599D1 (de) 1-hydroxypyrid-2-on-derivate enthaltende pharmazeutische zubereitungen.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
IL83684A0 (en) Arylcarboxylic acid derivatives,their preparation and their use as fungicides
FI870155L (fi) Menetelmä ksantaanikumia sisältävän, kiinteän lääkevalmisteen valmistamiseksi
NL192604B (nl) Ranitidinezouten, werkwijze voor de bereiding van deze zouten en farmaceutisch preparaat dat een dergelijk zout bevat.
DE3863678D1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
NL193267B (nl) Farmaceutisch preparaat in de vorm van een gelatinecapsule met een vulling die ranitidine-hydrochloride bevat.
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
DE69002748D1 (de) Waesserige loesung, die einen ginkgo-blaetterextrakt enthaelt.
FI933061A7 (fi) Vesipitoisen natriumhydroksidiliuoksen valmistumenetelmä
IT1182717B (it) Procedimento per ricavare ceftazidima da una sua soluzione acquosa
GB8711275D0 (en) Aqueous solution
FI840092A7 (fi) Steriloitavat foliomateriaalit vesipitoisten liuosten peruspakkauksiksi lääketieteen alalla.
AR243181A1 (es) Procedimiento de sintesis para obtener nuevos (benzofuran-2-il) imidazoles que tienen actividad farmaceutica y sus sales.
AU6156473A (en) A method for disinfecting human or animal skin
JPS57146722A (en) Pharmaceutical preparation having improved absorption
FI873800A7 (fi) Nor-kolaanihappojohdannaiset, menetelmä niiden valmistamiseksi, niiden käyttö sekä niitä sisältävät farmaseuttiset seokset.
KR900007816A (ko) 사이클로프로필-치환된 아졸릴메틸카비놀, 이의 제조방법 및 약제로서의 이의 용도